Methods for Rapid Antimicrobial Susceptibility Testing
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 15/464,240, filed Mar 20, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,501,772 | Methods for Rapid Antimicrobial Susceptibility Testing In force · High confidence | Selux Diagnostics, Inc. | In force | High confidence | ||
| US 10,982,254 | Methods for Rapid Antimicrobial Susceptibility Testing In force · High confidence | Selux Diagnostics, Inc. | In force | High confidence | ||
| US 9,834,808 | Methods for Rapid Antimicrobial Susceptibility Testing Lapsed Dec 5, 2025 on the fee record Ended Dec 5, 2025 · High confidence | Selux Diagnostics, Inc. | Lapsed Dec 5, 2025 on the fee record | Ended Dec 5, 2025 | High confidence | |
| Application 17/233,133 | Methods for Rapid Antimicrobial Susceptibility Testing Abandoned Abandoned May 15, 2025 | Selux Diagnostics, Inc. | Abandoned | Abandoned May 15, 2025 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Selux Diagnostics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.